UP!
| Period | Date | Adjusted Actuals EPS | GAAP EPS |
|---|---|---|---|
| Q2 2022 | 2022-08-02 | Future report Set alerts | |
| Q1 2022 | 2022-05-04 | -0.44 | -0.44 |
| Q4 2021 | 2022-02-15 | -0.43 | -0.43 |
| Q3 2021 | 2021-11-03 | -0.40 | -0.40 |
| Q2 2021 | 2021-08-04 | -0.35 | -0.35 |
| Q1 2021 | 2021-05-05 | -0.29 | -0.29 |
| Q4 2020 | 2021-02-24 | -0.33 | -0.33 |
| Q3 2020 | 2020-11-10 | 0.00 | 0.00 |
| Q2 2020 | 2020-08-10 | -0.26 | -0.26 |
| Q1 2020 | 2020-05-12 | -0.25 | -0.25 |
| 2016-07-11 | Reiterated Rating | Jefferies Group | Buy | $125.00 to $113.00 |
| 2016-06-02 | Reiterated Rating | KeyBanc | Buy | |
| 2016-06-02 | Reiterated Rating | KeyCorp | Buy | |
| 2016-05-31 | Reiterated Rating | Morgan Stanley | Hold | |
| 2016-05-19 | Reiterated Rating | Jefferies Group | Buy | $125.00 |
| 2016-04-02 | Reiterated Rating | Jefferies Group | Buy | |
| 2016-02-08 | Reiterated Rating | Jefferies | Buy | $135.00 to $125.00 |
| 2016-02-08 | Reiterated Rating | Jefferies Group | Buy | $135.00 to $125.00 |
| 2016-02-05 | Lower Price Target | Jefferies Group | Buy | $135.00 to $125.00 |
| 2015-11-18 | Reiterated Rating | Jefferies Group | Buy | $135.00 |
| 2015-11-18 | Lower Price Target | Dougherty & Co | Buy | $130.00 to $62.00 |
| 2015-10-23 | Lower Price Target | Piper Jaffray | $130.00 to $109.00 | |
| 2015-10-23 | Lower Price Target | KeyBanc | Overweight | $129.00 to $104.00 |
| 2015-10-23 | Lower Price Target | RBC Capital | Outperform | $114.00 to $92.00 |
| 2015-10-23 | Lower Price Target | Piper Jaffray Cos. | $130.00 to $109.00 | |
| 2015-10-23 | Lower Price Target | Royal Bank Of Canada | Outperform | $114.00 to $92.00 |
| 2015-09-18 | Boost Price Target | KeyBanc | Overweight | $119.00 to $129.00 |
| 2015-08-13 | Boost Price Target | Piper Jaffray | Overweight | $130.00 |
| 2015-08-03 | Initiated Coverage | Jefferies Group | Buy | $135.00 |
| 2015-07-24 | Boost Price Target | RBC Capital | Outperform | $69.00 to $114.00 |
| 2015-06-24 | Boost Price Target | Dougherty & Co | Buy | $70.00 to $130.00 |
| 2015-06-23 | Initiated Coverage | Bank of America | Buy | $105.00 |
| 2015-06-23 | Initiated Coverage | Bank of America Corp. | Buy | $105.00 |
| 2015-06-17 | Reiterated Rating | Piper Jaffray | Overweight | $69.00 to $102.00 |
| 2015-06-10 | Initiated Coverage | KeyBanc | Overweight | $106.00 |
| 2015-06-05 | Initiated Coverage | Goldman Sachs | Buy | $88.00 |
| 2015-06-05 | Initiated Coverage | Goldman Sachs Group Inc. | Buy | $88.00 |
| 2015-05-13 | Boost Price Target | RBC Capital | Outperform | $45.00 to $69.00 |
| 2015-04-27 | Boost Price Target | Dougherty & Co | Buy | $55.00 to $70.00 |
| 2015-04-24 | Boost Price Target | Deutsche Bank | Hold | $44.00 to $61.00 |
| 2015-04-24 | Boost Price Target | Deutsche Bank AG | Hold | $44.00 to $61.00 |
| 2015-03-27 | Set Price Target | Piper Jaffray | Buy | $46.00 to $56.00 |
| 2015-02-20 | Boost Price Target | Jefferies Group | Market Outperform | $40.00 to $44.00 |
| 2015-02-20 | Boost Price Target | Piper Jaffray | Buy | $45.00 to $46.00 |
| 2014-12-11 | Initiated Coverage | JMP Securities | Outperform | |
| 2014-11-13 | Downgrade | Deutsche Bank | Buy to Hold | $35.00 to $36.00 |
| 2014-10-30 | Reiterated Rating | Deutsche Bank | Buy | $33.00 to $35.00 |
| 2014-10-15 | Upgrade | Deutsche Bank | Hold to Buy | $28.50 to $33.00 |
| 2014-10-01 | Initiated Coverage | RBC Capital | Outperform | $33.00 |
| 2014-07-21 | Initiated Coverage | Dougherty & Co | Buy | |
| 2014-07-21 | Initiated Coverage | Morgan Stanley | Equal Weight | |
| 2014-07-21 | Initiated Coverage | Piper Jaffray | Overweight | $32.00 |
| 2014-07-21 | Initiated Coverage | Deutsche Bank | Hold to Hold | $28.50 |
| 2014-07-21 | Initiated Coverage | Goldman Sachs | Buy | $32.00 |
| 2016-07-11 | Reiterated Rating | Jefferies Group | Buy | $125.00 to $113.00 |
| 2016-06-02 | Reiterated Rating | KeyBanc | Buy | |
| 2016-06-02 | Reiterated Rating | KeyCorp | Buy | |
| 2016-05-31 | Reiterated Rating | Morgan Stanley | Hold | |
| 2016-05-19 | Reiterated Rating | Jefferies Group | Buy | $125.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In ADPT 157 funds of 2220 total. Show all
| Fund name | Ticker shares |
|---|---|
| VIKING GLOBAL INVESTORS LP | 29.99M |
| PRICE T ROWE ASSOCIATES INC /MD/ | 12.42M |
| Matrix Capital Management Company, LP | 11.57M |
| Vanguard Group, Inc | 11.09M |
| BlackRock Inc. | 5.97M |
| Nikko Asset Management Americas, Inc. | 4.14M |
| Sumitomo Mitsui Trust Holdings, Inc. | 4.13M |
| STATE STREET CORP | 1.87M |
| GEODE CAPITAL MANAGEMENT, LLC | 1.41M |
| Neuberger Berman Group LLC | 1.27M |
| BlackRock Fund Advisors | 1.20M |
| GOLDMAN SACHS GROUP INC | 1.18M |
| Senator Investment Group LP | 1.00M |
| Marshall Wace LLP | 0.93M |
| Bank of New York Mellon Corp | 0.91M |
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| Rosenberg Daniel | 33.82% (3317817) | ADPT / |
| PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 16.25% (1594352) | ADPT / BPHX / CHCI / MCHX / NATR / PAR / PIP / |
| HALL THOMAS S President and CEO | 1.68% (164408) | ADPT / |
| Cherrington Graham Chief Operating Officer | 0.58% (57201) | ADPT / |
| Fielding Tim Treasurer & Chief Fin Officer | 0.15% (14458) | ADPT / |
| NAPOLITANO STEVEN V | 0.15% (14427) | ADPT / |
| Sterling Fund Management LLC | 0.15% (14427) | ADPT / |
| JORDAN ANDREW M Chief Marketing Officer | 0.13% (13030) | ADPT / |
| Muzzarelli James Executive Medical Director | 0.13% (13030) | ADPT / |
| Bowen Traci VP of Human Resources | 0.13% (13030) | ADPT / |
| TAYLOR RONALD L | 0.13% (12722) | ADPT / DV / FNTC / |
| Covert Richard | 0.13% (12722) | ADPT / |
| Vender Jeffery S. | 0.13% (12722) | ADPT / |
| MENGERT STEPHEN M | 0.11% (10606) | ADPT / |
| Sterling Capital Partners III, LLC | 0.06% (5593) | ADPT / |
| Scott Gregory W. | 0.04% (3888) | ADPT / UAM / |
UM